{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "24",
                "@timestamp": "2023-08-24T20:32:44.000044-04:00",
                "@year": "2023",
                "@month": "08"
            },
            "ait:date-sort": {
                "@day": "11",
                "@year": "2023",
                "@month": "07"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {
                    "xocs:funding-agency-matched-string": "National Institutes of Health",
                    "xocs:funding-agency-acronym": "NIH",
                    "xocs:funding-agency": "National Institutes of Health",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000002",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "National Cancer Institute",
                    "xocs:funding-agency-acronym": "NCI",
                    "xocs:funding-agency": "National Cancer Institute",
                    "xocs:funding-id": "P30 CA008748",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000054",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "National Center for Advancing Translational Sciences",
                    "xocs:funding-agency-acronym": "NCATS",
                    "xocs:funding-agency": "National Center for Advancing Translational Sciences",
                    "xocs:funding-id": "UL1-TR002494",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100006108",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Novartis Pharmaceuticals, Inc.",
                    "xocs:funding-agency-acronym": "NPC",
                    "xocs:funding-agency": "Novartis Pharmaceuticals Corporation",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100008272",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-08-19T22:25:28.989Z",
            "xocs:funding-text": "This research was supported in part by a grant from Novartis Pharmaceuticals, Inc. (D.L.P.), National Institutes of Health, National Cancer Institute grant P30 CA008748 (M.-A.P.), and the National Center for Advancing Translational Sciences of the National Institutes of Health Award UL1-TR002494 (V.B.).",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009343",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Adult Bone Marrow Transplant Service"},
                                {"$": "Memorial Sloan Kettering Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009343",
                                "@dptid": "109501192"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "OB2BibRecID-950129089-e499c3918c3c16fc98f79eec66e06d5e-1",
                            "ce:source-text": "Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY",
                            "@dptid": "109501192"
                        },
                        "author": [
                            {
                                "ce:given-name": "Kitsada",
                                "preferred-name": {
                                    "ce:given-name": "Kitsada",
                                    "ce:initials": "K.",
                                    "ce:surname": "Wudhikarn",
                                    "ce:indexed-name": "Wudhikarn K."
                                },
                                "@author-instance-id": "OB2BibRecID-950129089-7a309d2db05f8303cc6f091e2ce91e16-1",
                                "@seq": "1",
                                "ce:initials": "K.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wudhikarn",
                                "@auid": "37091810400",
                                "ce:indexed-name": "Wudhikarn K."
                            },
                            {
                                "ce:given-name": "Ana Alarcon",
                                "preferred-name": {
                                    "ce:given-name": "Ana Alarcon",
                                    "ce:initials": "A.A.",
                                    "ce:surname": "Tomas",
                                    "ce:indexed-name": "Tomas A.A."
                                },
                                "@author-instance-id": "OB2BibRecID-950129089-cef249c706db093366a6d63e5f049b58-1",
                                "@seq": "2",
                                "ce:initials": "A.A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Tomas",
                                "@auid": "57216155516",
                                "@orcid": "0000-0002-6290-1061",
                                "ce:indexed-name": "Tomas A.A."
                            },
                            {
                                "ce:given-name": "Miguel-Angel",
                                "preferred-name": {
                                    "ce:given-name": "Miguel Angel",
                                    "ce:initials": "M.A.",
                                    "ce:surname": "Perales",
                                    "ce:indexed-name": "Perales M.A."
                                },
                                "@author-instance-id": "OB2BibRecID-950129089-2a6c3a6f97f2fbc3e94840a5c8a4380d-1",
                                "@seq": "15",
                                "ce:initials": "M.-A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Perales",
                                "@auid": "6701893624",
                                "@orcid": "0000-0002-5910-4571",
                                "ce:indexed-name": "Perales M.-A."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Hematology"},
                                {"$": "Research Unit in Translational Hematology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "125772692"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-950129089-fa901c2c2d29e9ac8ef36dfaccecdd6b-1",
                            "ce:source-text": "Division of Hematology and Research Unit in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "125772692"
                        },
                        "author": [{
                            "ce:given-name": "Kitsada",
                            "preferred-name": {
                                "ce:given-name": "Kitsada",
                                "ce:initials": "K.",
                                "ce:surname": "Wudhikarn",
                                "ce:indexed-name": "Wudhikarn K."
                            },
                            "@author-instance-id": "OB2BibRecID-950129089-7a309d2db05f8303cc6f091e2ce91e16-1",
                            "@seq": "1",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Wudhikarn",
                            "@auid": "37091810400",
                            "ce:indexed-name": "Wudhikarn K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Spain",
                            "@afid": "60033237",
                            "@country": "esp",
                            "city": "Madrid",
                            "organization": [
                                {"$": "Division of Hematology and Hemotherapy"},
                                {"$": "Hospital General Universitario Gregorio Marañón"}
                            ],
                            "affiliation-id": {
                                "@afid": "60033237",
                                "@dptid": "115130570"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-950129089-df56bf42da9c755891f02f397572d85e-1",
                            "ce:source-text": "Division of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain",
                            "@dptid": "115130570"
                        },
                        "author": [{
                            "ce:given-name": "Ana Alarcon",
                            "preferred-name": {
                                "ce:given-name": "Ana Alarcon",
                                "ce:initials": "A.A.",
                                "ce:surname": "Tomas",
                                "ce:indexed-name": "Tomas A.A."
                            },
                            "@author-instance-id": "OB2BibRecID-950129089-cef249c706db093366a6d63e5f049b58-1",
                            "@seq": "2",
                            "ce:initials": "A.A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tomas",
                            "@auid": "57216155516",
                            "@orcid": "0000-0002-6290-1061",
                            "ce:indexed-name": "Tomas A.A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009343",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Department of Epidemiology and Biostatistics"},
                                {"$": "Memorial Sloan Kettering Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009343",
                                "@dptid": "113531958"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "OB2BibRecID-950129089-8f977e023b2b0c18fd6dd5c98b9ab39a-1",
                            "ce:source-text": "Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY",
                            "@dptid": "113531958"
                        },
                        "author": [
                            {
                                "ce:given-name": "Jessica R.",
                                "preferred-name": {
                                    "ce:given-name": "Jessica R.",
                                    "ce:initials": "J.R.",
                                    "ce:surname": "Flynn",
                                    "ce:indexed-name": "Flynn J.R."
                                },
                                "@author-instance-id": "OB2BibRecID-950129089-6aec9aa8df93a8f456088e15328ca9da-1",
                                "@seq": "3",
                                "ce:initials": "J.R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Flynn",
                                "@auid": "57203165820",
                                "@orcid": "0000-0001-8310-6684",
                                "ce:indexed-name": "Flynn J.R."
                            },
                            {
                                "ce:given-name": "Sean M.",
                                "preferred-name": {
                                    "ce:given-name": "Sean M.",
                                    "ce:initials": "S.M.",
                                    "ce:surname": "Devlin",
                                    "ce:indexed-name": "Devlin S.M."
                                },
                                "@author-instance-id": "OB2BibRecID-950129089-103bc3c76147d14e9178492ee31ab578-1",
                                "@seq": "4",
                                "ce:initials": "S.M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Devlin",
                                "@auid": "55515156100",
                                "ce:indexed-name": "Devlin S.M."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60023009",
                            "@country": "usa",
                            "city": "Philadelphia",
                            "organization": [
                                {"$": "Blood and Marrow Transplant and Cellular Therapy Program"},
                                {"$": "Abramson Cancer Center"},
                                {"$": "University of Pennsylvania"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60023009",
                                    "@dptid": "118646800"
                                },
                                {"@afid": "60006297"}
                            ],
                            "state": "PA",
                            "@affiliation-instance-id": "OB2BibRecID-950129089-684aadd05f1a7424f14ee153cebc6e63-1",
                            "ce:source-text": "Blood and Marrow Transplant and Cellular Therapy Program, Abramson Cancer Center, The University of Pennsylvania, Philadelphia, PA",
                            "@dptid": "118646800"
                        },
                        "author": [
                            {
                                "ce:given-name": "Jamie",
                                "preferred-name": {
                                    "ce:given-name": "Jamie",
                                    "ce:initials": "J.",
                                    "ce:surname": "Brower",
                                    "ce:indexed-name": "Brower J."
                                },
                                "@author-instance-id": "OB2BibRecID-950129089-2e1e902e03e97e3063d0db054084f065-1",
                                "@seq": "5",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Brower",
                                "@auid": "57057255300",
                                "@orcid": "0000-0003-1614-8934",
                                "ce:indexed-name": "Brower J."
                            },
                            {
                                "ce:given-name": "Stephen J.",
                                "preferred-name": {
                                    "ce:given-name": "Stephen J.",
                                    "ce:initials": "S.J.",
                                    "ce:surname": "Schuster",
                                    "ce:indexed-name": "Schuster S.J."
                                },
                                "@author-instance-id": "OB2BibRecID-950129089-e72fba57356b973bb69784e9699ce335-1",
                                "@seq": "11",
                                "ce:initials": "S.J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Schuster",
                                "@auid": "7202029256",
                                "ce:indexed-name": "Schuster S.J."
                            },
                            {
                                "ce:given-name": "David L.",
                                "preferred-name": {
                                    "ce:given-name": "David L.",
                                    "ce:initials": "D.L.",
                                    "ce:surname": "Porter",
                                    "ce:indexed-name": "Porter D.L."
                                },
                                "@author-instance-id": "OB2BibRecID-950129089-f86522c71eea358fb5b55f8b4052a51f-1",
                                "@seq": "12",
                                "ce:initials": "D.L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Porter",
                                "@auid": "13605387900",
                                "ce:indexed-name": "Porter D.L."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60029445",
                            "@country": "usa",
                            "city": "Minneapolis",
                            "organization": [
                                {"$": "Division of Hematology"},
                                {"$": "Oncology"},
                                {"$": "Transplantation"},
                                {"$": "Department of Medicine"},
                                {"$": "University of Minnesota"}
                            ],
                            "affiliation-id": {
                                "@afid": "60029445",
                                "@dptid": "104490668"
                            },
                            "state": "MN",
                            "@affiliation-instance-id": "OB2BibRecID-950129089-433153ca4cc5f6b2d6b756c8eface8ea-1",
                            "ce:source-text": "Division of Hematology, Oncology, Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN",
                            "@dptid": "104490668"
                        },
                        "author": [{
                            "ce:given-name": "Veronika",
                            "preferred-name": {
                                "ce:given-name": "Veronika",
                                "ce:initials": "V.",
                                "ce:surname": "Bachanova",
                                "ce:indexed-name": "Bachanova V."
                            },
                            "@author-instance-id": "OB2BibRecID-950129089-f5fdb7983681c26ba32a6a858fc9b561-1",
                            "@seq": "6",
                            "ce:initials": "V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Bachanova",
                            "@auid": "23975811700",
                            "ce:indexed-name": "Bachanova V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60015023",
                            "@country": "usa",
                            "city": "Houston",
                            "organization": [
                                {"$": "Division of Cancer Medicine"},
                                {"$": "Department of Lymphoma/Myeloma"},
                                {"$": "University of Texas MD Anderson Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60015023",
                                "@dptid": "128453254"
                            },
                            "state": "TX",
                            "@affiliation-instance-id": "OB2BibRecID-950129089-ea22f3fa9a726237c6ac688169d023e6-1",
                            "ce:source-text": "Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX",
                            "@dptid": "128453254"
                        },
                        "author": [{
                            "ce:given-name": "Loretta J.",
                            "preferred-name": {
                                "ce:given-name": "Loretta J.",
                                "ce:initials": "L.J.",
                                "ce:surname": "Nastoupil",
                                "ce:indexed-name": "Nastoupil L.J."
                            },
                            "@author-instance-id": "OB2BibRecID-950129089-a5a4e7409adb678554061d1bf1f4ebbd-1",
                            "@seq": "7",
                            "ce:initials": "L.J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Nastoupil",
                            "@auid": "55208211700",
                            "@orcid": "0000-0001-6071-8610",
                            "ce:indexed-name": "Nastoupil L.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60015457",
                            "@country": "usa",
                            "city": "Kansas City",
                            "organization": [
                                {"$": "Division of Hematologic Malignancies and Cellular Therapeutics"},
                                {"$": "Department of Medicine"},
                                {"$": "University of Kansas"}
                            ],
                            "affiliation-id": {
                                "@afid": "60015457",
                                "@dptid": "108372771"
                            },
                            "state": "KS",
                            "@affiliation-instance-id": "OB2BibRecID-950129089-61693d58666d02218c1ec20e72728912-1",
                            "ce:source-text": "Division of Hematologic Malignancies and Cellular Therapeutics, Department of Medicine, The University of Kansas, Kansas City, KS",
                            "@dptid": "108372771"
                        },
                        "author": [{
                            "ce:given-name": "Joseph P.",
                            "preferred-name": {
                                "ce:given-name": "Joseph P.",
                                "ce:initials": "J.P.",
                                "ce:surname": "McGuirk",
                                "ce:indexed-name": "McGuirk J.P."
                            },
                            "@author-instance-id": "OB2BibRecID-950129089-9dce3380c019b3476ca2c192802fe0cb-1",
                            "@seq": "8",
                            "ce:initials": "J.P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "McGuirk",
                            "@auid": "7005232105",
                            "@orcid": "0000-0002-0539-4796",
                            "ce:indexed-name": "McGuirk J.P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60016733",
                            "@country": "usa",
                            "city": "Portland",
                            "organization": [
                                {"$": "Center for Hematologic Malignancies"},
                                {"$": "Knight Cancer Institute"},
                                {"$": "Oregon Health and Science University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60016733",
                                "@dptid": "103862221"
                            },
                            "state": "OR",
                            "@affiliation-instance-id": "OB2BibRecID-950129089-1e390cdbd33f05ef47a79f3f3d86cd3f-1",
                            "ce:source-text": "Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR",
                            "@dptid": "103862221"
                        },
                        "author": [{
                            "ce:given-name": "Richard T.",
                            "preferred-name": {
                                "ce:given-name": "Richard T.",
                                "ce:initials": "R.T.",
                                "ce:surname": "Maziarz",
                                "ce:indexed-name": "Maziarz R.T."
                            },
                            "@author-instance-id": "OB2BibRecID-950129089-a4ff6b244f158644f83cc54f22960187-1",
                            "@seq": "9",
                            "ce:initials": "R.T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Maziarz",
                            "@auid": "7004295697",
                            "ce:indexed-name": "Maziarz R.T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60024890",
                            "@country": "usa",
                            "city": "Nashville",
                            "organization": [
                                {"$": "Division of Hematology/Oncology"},
                                {"$": "Department of Medicine"},
                                {"$": "Vanderbilt-Ingram Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60024890",
                                "@dptid": "112751841"
                            },
                            "state": "TN",
                            "@affiliation-instance-id": "OB2BibRecID-950129089-71e05b3ebeb4fbce66a2982278bfb4a3-1",
                            "ce:source-text": "Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN",
                            "@dptid": "112751841"
                        },
                        "author": [{
                            "ce:given-name": "Olalekan O.",
                            "preferred-name": {
                                "ce:given-name": "Olalekan O.",
                                "ce:initials": "O.O.",
                                "ce:surname": "Oluwole",
                                "ce:indexed-name": "Oluwole O.O."
                            },
                            "@author-instance-id": "OB2BibRecID-950129089-504f6578a7cc771c490090a8dec746be-1",
                            "@seq": "10",
                            "ce:initials": "O.O.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Oluwole",
                            "@auid": "55744271900",
                            "@orcid": "0000-0001-8525-9641",
                            "ce:indexed-name": "Oluwole O.O."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60029278",
                            "@country": "usa",
                            "city": "Chicago",
                            "organization": [
                                {"$": "David and Etta Jonas Center for Cellular Therapy"},
                                {"$": "University of Chicago"}
                            ],
                            "affiliation-id": {"@afid": "60029278"},
                            "state": "IL",
                            "@affiliation-instance-id": "OB2BibRecID-950129089-f67eabecdb52dbb5d48692809f0573aa-1",
                            "ce:source-text": "The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL"
                        },
                        "author": [
                            {
                                "ce:given-name": "Michael R.",
                                "preferred-name": {
                                    "ce:given-name": "Michael R.",
                                    "ce:initials": "M.R.",
                                    "ce:surname": "Bishop",
                                    "ce:indexed-name": "Bishop M.R."
                                },
                                "@author-instance-id": "OB2BibRecID-950129089-845135647de4f2021f91b4bb667566fb-1",
                                "@seq": "13",
                                "ce:initials": "M.R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Bishop",
                                "@auid": "35413554300",
                                "ce:indexed-name": "Bishop M.R."
                            },
                            {
                                "ce:given-name": "Peter A.",
                                "preferred-name": {
                                    "ce:given-name": "Peter A.",
                                    "ce:initials": "P.A.",
                                    "ce:surname": "Riedell",
                                    "ce:indexed-name": "Riedell P.A."
                                },
                                "@author-instance-id": "OB2BibRecID-950129089-aab50f7d27aec0738f56b19b972946fe-1",
                                "@seq": "14",
                                "ce:initials": "P.A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Riedell",
                                "@auid": "56210729200",
                                "@orcid": "0000-0003-2719-0580",
                                "ce:indexed-name": "Riedell P.A."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60007997",
                            "@country": "usa",
                            "city": "New York",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Weill Cornell Medical College"}
                            ],
                            "affiliation-id": {
                                "@afid": "60007997",
                                "@dptid": "112748380"
                            },
                            "state": "NY",
                            "@affiliation-instance-id": "OB2BibRecID-950129089-77ac51e0890fea75ed60817cc003daa6-1",
                            "ce:source-text": "Department of Medicine, Weill Cornell Medical College, New York, NY",
                            "@dptid": "112748380"
                        },
                        "author": [{
                            "ce:given-name": "Miguel-Angel",
                            "preferred-name": {
                                "ce:given-name": "Miguel Angel",
                                "ce:initials": "M.A.",
                                "ce:surname": "Perales",
                                "ce:indexed-name": "Perales M.A."
                            },
                            "@author-instance-id": "OB2BibRecID-950129089-2a6c3a6f97f2fbc3e94840a5c8a4380d-1",
                            "@seq": "15",
                            "ce:initials": "M.-A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Perales",
                            "@auid": "6701893624",
                            "@orcid": "0000-0002-5910-4571",
                            "ce:indexed-name": "Perales M.-A."
                        }]
                    },
                    {"collaboration": {
                        "@seq": "16",
                        "@collaboration-instance-id": "OB2BibRecID-950129089-d4bbaf8a3eba50a4d174ba244c980520-1",
                        "ce:text": "Cell Therapy Consortium",
                        "ce:indexed-name": "Cell Therapy Consortium"
                    }}
                ],
                "citation-title": "Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy",
                "abstracts": "© 2023 by The American Society of Hematology.CD19 chimeric antigen receptor (CAR) T-cell therapy represents a breakthrough for patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), inducing sustained remissions in these patients. However, CAR T cells can result in significant toxicities. Preinfusion disease burden is associated with toxicities and outcomes after CAR T-cell therapy. We identified 33 patients with R/R DLBCL treated at 8 academic centers who had no detectable disease at the time of CAR T-cell therapy. The median time from leukapheresis to CAR T-cell infusion was 48 (19-193) days. Nine patients received axicabtagene ciloleucel, and 24 received tisagenlecleucel. There was no severe (grade ≥3) cytokine release syndrome, and only 1 patient developed severe neurotoxicity (grade 4). After a median follow-up of 16 months, 13 patients relapsed (39.4%) and 6 died (18.1%). One-year event-free survival and overall survival were 59.6% and 81.3%, respectively. Our findings suggest that, in patients with R/R DLBCL who have an indication for CAR T-cell therapy, treating patients in complete remission at the time of infusion is feasible, safe, and associated with favorable disease control. Further exploration in a larger clinical trial setting is warranted.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "address-part": "530 East 74th St, Box 59",
                        "postal-code": "10021",
                        "@country": "usa",
                        "city": "New York",
                        "organization": [
                            {"$": "Department of Medicine"},
                            {"$": "Adult Bone Marrow Transplant Service"},
                            {"$": "Memorial Sloan Kettering Cancer Center"}
                        ],
                        "state": "NY",
                        "@affiliation-instance-id": "OB2BibRecID-950129089-afeca8760d268bd2f3c0b0d93bb5d94b-1",
                        "ce:source-text": "Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, 530 East 74th St, Box 59, New York, NY 10021"
                    },
                    "person": {
                        "ce:given-name": "Miguel-Angel",
                        "@author-instance-id": "OB2BibRecID-950129089-6c8aac8ad49f6307729d4d87020b298a-1",
                        "ce:initials": "M.-A.",
                        "ce:surname": "Perales",
                        "ce:indexed-name": "Perales M.-A."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Blood Adv.",
                    "website": {"ce:e-address": {
                        "$": "https://ashpublications.org/bloodadvances/article/7/13/3192/487059/Low-toxicity-and-excellent-outcomes-in-patients",
                        "@type": "email"
                    }},
                    "@country": "usa",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": [
                        {
                            "$": "24739537",
                            "@type": "electronic"
                        },
                        {
                            "$": "24739529",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "7",
                            "@issue": "13"
                        },
                        "pagerange": {
                            "@first": "3192",
                            "@last": "3198"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "American Society of Hematology"},
                    "sourcetitle": "Blood Advances",
                    "@srcid": "21100886825",
                    "publicationdate": {
                        "month": "07",
                        "year": "2023",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "11 July 2023"
                        },
                        "day": "11"
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "25",
                                    "classification-description": "Hematology"
                                },
                                {
                                    "classification-code": "26",
                                    "classification-description": "Immunology, Serology and Transplantation"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2720"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": [
                            {
                                "cas-registry-number": [
                                    {"$": "16506-27-7"},
                                    {"$": "3543-75-7"}
                                ],
                                "chemical-name": "bendamustine"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "50-18-0"},
                                    {"$": "6055-19-2"}
                                ],
                                "chemical-name": "cyclophosphamide"
                            },
                            {
                                "cas-registry-number": "50-02-2",
                                "chemical-name": "dexamethasone"
                            },
                            {
                                "cas-registry-number": "21679-14-1",
                                "chemical-name": "fludarabine"
                            },
                            {
                                "cas-registry-number": "1823078-37-0",
                                "chemical-name": "tisagenlecleucel T"
                            },
                            {
                                "cas-registry-number": "375823-41-9",
                                "chemical-name": "tocilizumab"
                            }
                        ]
                    }}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This research was supported in part by a grant from Novartis Pharmaceuticals, Inc. (D.L.P.), National Institutes of Health, National Cancer Institute grant P30 CA008748 (M.-A.P.), and the National Center for Advancing Translational Sciences of the National Institutes of Health Award UL1-TR002494 (V.B.).",
                        "@xml:lang": "eng"
                    },
                    "grant": [
                        {
                            "grant-id": "P30 CA008748",
                            "grant-acronym": "NIH",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "National Institutes of Health"
                            },
                            "grant-agency-id": "100000002"
                        },
                        {
                            "grant-id": "UL1-TR002494",
                            "grant-acronym": "NIH",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "National Institutes of Health"
                            },
                            "grant-agency-id": "100000002"
                        }
                    ]
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "24",
                    "@timestamp": "BST 06:45:43",
                    "@year": "2023",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2026433834",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "639485755",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "950129089",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230768697",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "36355838",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20232354744",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20233068174",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20239027558094",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85167904304",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85167904304",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.1182/bloodadvances.2022008294"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "21",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Neelapu SS, Locke FL, Bartlett NL, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N Engl J Med. 2017;377(26): 2531-2544.",
                        "@reference-instance-id": "OB2BibRecID-950129089-d0d30dcd22c041262656a341ff9dab20-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85040170618",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "377",
                                    "@issue": "26"
                                },
                                "pagerange": {
                                    "@first": "2531",
                                    "@last": "2544"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SS",
                                        "@_fa": "true",
                                        "ce:surname": "Neelapu",
                                        "ce:indexed-name": "Neelapu SS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "FL",
                                        "@_fa": "true",
                                        "ce:surname": "Locke",
                                        "ce:indexed-name": "Locke FL"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "NL",
                                        "@_fa": "true",
                                        "ce:surname": "Bartlett",
                                        "ce:indexed-name": "Bartlett NL"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Neelapu SS, Locke FL, Bartlett NL, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N Engl J Med. 2017;377(26): 2531-2544."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Schuster SJ, Bishop MR, Tam CS, et al. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N Engl J Med. 2019;380(1): 45-56.",
                        "@reference-instance-id": "OB2BibRecID-950129089-15002f4cd7e365d501145d2d867ccb7b-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85058995720",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "380",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "45",
                                    "@last": "56"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SJ",
                                        "@_fa": "true",
                                        "ce:surname": "Schuster",
                                        "ce:indexed-name": "Schuster SJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MR",
                                        "@_fa": "true",
                                        "ce:surname": "Bishop",
                                        "ce:indexed-name": "Bishop MR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "CS",
                                        "@_fa": "true",
                                        "ce:surname": "Tam",
                                        "ce:indexed-name": "Tam CS"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Schuster SJ, Bishop MR, Tam CS, et al. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N Engl J Med. 2019;380(1): 45-56."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Abramson JS, Palomba ML, Gordon LI, et al. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. Lancet. 2020;396(10254):839-852.",
                        "@reference-instance-id": "OB2BibRecID-950129089-330b8e1005b28e793dcd78c0751b91bc-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85090978508",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "396",
                                    "@issue": "10254"
                                },
                                "pagerange": {
                                    "@first": "839",
                                    "@last": "852"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JS",
                                        "@_fa": "true",
                                        "ce:surname": "Abramson",
                                        "ce:indexed-name": "Abramson JS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "ML",
                                        "@_fa": "true",
                                        "ce:surname": "Palomba",
                                        "ce:indexed-name": "Palomba ML"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "LI",
                                        "@_fa": "true",
                                        "ce:surname": "Gordon",
                                        "ce:indexed-name": "Gordon LI"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Abramson JS, Palomba ML, Gordon LI, et al. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. Lancet. 2020;396(10254):839-852."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Jain T, Bar M, Kansagra AJ, et al. Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant. 2019; 25(12):2305-2321.",
                        "@reference-instance-id": "OB2BibRecID-950129089-5ce1be82bbc74b772c2569062d8133d4-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the American Society for Transplantation and Cellular Therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85072519127",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "25",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "2305",
                                    "@last": "2321"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Jain",
                                        "ce:indexed-name": "Jain T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Bar",
                                        "ce:indexed-name": "Bar M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AJ",
                                        "@_fa": "true",
                                        "ce:surname": "Kansagra",
                                        "ce:indexed-name": "Kansagra AJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biol Blood Marrow Transplant"
                        },
                        "ce:source-text": "Jain T, Bar M, Kansagra AJ, et al. Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant. 2019; 25(12):2305-2321."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Dean EA, Mhaskar RS, Lu H, et al. High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv. 2020;4(14):3268-3276.",
                        "@reference-instance-id": "OB2BibRecID-950129089-2abb70bb6394fcbfd76135d554385a54-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85090452202",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "14"
                                },
                                "pagerange": {
                                    "@first": "3268",
                                    "@last": "3276"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "EA",
                                        "@_fa": "true",
                                        "ce:surname": "Dean",
                                        "ce:indexed-name": "Dean EA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RS",
                                        "@_fa": "true",
                                        "ce:surname": "Mhaskar",
                                        "ce:indexed-name": "Mhaskar RS"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Dean EA, Mhaskar RS, Lu H, et al. High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv. 2020;4(14):3268-3276."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Hirayama AV, Gauthier J, Hay KA, et al. The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells. Blood. 2019;133(17):1876-1887.",
                        "@reference-instance-id": "OB2BibRecID-950129089-7c98e440eb916443f5bddf2ef6bfb8cb-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85065170101",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "133",
                                    "@issue": "17"
                                },
                                "pagerange": {
                                    "@first": "1876",
                                    "@last": "1887"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AV",
                                        "@_fa": "true",
                                        "ce:surname": "Hirayama",
                                        "ce:indexed-name": "Hirayama AV"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Gauthier",
                                        "ce:indexed-name": "Gauthier J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "KA",
                                        "@_fa": "true",
                                        "ce:surname": "Hay",
                                        "ce:indexed-name": "Hay KA"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Hirayama AV, Gauthier J, Hay KA, et al. The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells. Blood. 2019;133(17):1876-1887."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Locke FL, Rossi JM, Neelapu SS, et al. Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv. 2020;4(19):4898-4911.",
                        "@reference-instance-id": "OB2BibRecID-950129089-e238a675918a9694813b50a0a2892d97-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85095741006",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "4",
                                    "@issue": "19"
                                },
                                "pagerange": {
                                    "@first": "4898",
                                    "@last": "4911"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "FL",
                                        "@_fa": "true",
                                        "ce:surname": "Locke",
                                        "ce:indexed-name": "Locke FL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Rossi",
                                        "ce:indexed-name": "Rossi JM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SS",
                                        "@_fa": "true",
                                        "ce:surname": "Neelapu",
                                        "ce:indexed-name": "Neelapu SS"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Locke FL, Rossi JM, Neelapu SS, et al. Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv. 2020;4(19):4898-4911."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Mueller KT, Maude SL, Porter DL, et al. Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia. Blood. 2017;130(21):2317-2325.",
                        "@reference-instance-id": "OB2BibRecID-950129089-bbb7db87a17ee538730ffabbd926435b-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85034844703",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "130",
                                    "@issue": "21"
                                },
                                "pagerange": {
                                    "@first": "2317",
                                    "@last": "2325"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "KT",
                                        "@_fa": "true",
                                        "ce:surname": "Mueller",
                                        "ce:indexed-name": "Mueller KT"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SL",
                                        "@_fa": "true",
                                        "ce:surname": "Maude",
                                        "ce:indexed-name": "Maude SL"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "DL",
                                        "@_fa": "true",
                                        "ce:surname": "Porter",
                                        "ce:indexed-name": "Porter DL"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Mueller KT, Maude SL, Porter DL, et al. Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia. Blood. 2017;130(21):2317-2325."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Bishop MR, Maziarz RT, Waller EK, et al. Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion. Blood Adv. 2019;3(14):2230-2236.",
                        "@reference-instance-id": "OB2BibRecID-950129089-da08c0ca563a8fb82375e7ed608346a7-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85069681114",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "3",
                                    "@issue": "14"
                                },
                                "pagerange": {
                                    "@first": "2230",
                                    "@last": "2236"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MR",
                                        "@_fa": "true",
                                        "ce:surname": "Bishop",
                                        "ce:indexed-name": "Bishop MR"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RT",
                                        "@_fa": "true",
                                        "ce:surname": "Maziarz",
                                        "ce:indexed-name": "Maziarz RT"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "EK",
                                        "@_fa": "true",
                                        "ce:surname": "Waller",
                                        "ce:indexed-name": "Waller EK"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood Adv"
                        },
                        "ce:source-text": "Bishop MR, Maziarz RT, Waller EK, et al. Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion. Blood Adv. 2019;3(14):2230-2236."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Riedell PA, Hwang WT, Nastoupil LJ, et al. Patterns of use, outcomes, and resource utilization among recipients of commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B cell lymphomas. Transplant Cell Ther. 2022;28(10):669-676.",
                        "@reference-instance-id": "OB2BibRecID-950129089-1adf808eb8df84594f454540be771998-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Patterns of use, outcomes, and resource utilization among recipients of commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B cell lymphomas"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85136273493",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "669",
                                    "@last": "676"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "PA",
                                        "@_fa": "true",
                                        "ce:surname": "Riedell",
                                        "ce:indexed-name": "Riedell PA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WT",
                                        "@_fa": "true",
                                        "ce:surname": "Hwang",
                                        "ce:indexed-name": "Hwang WT"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "LJ",
                                        "@_fa": "true",
                                        "ce:surname": "Nastoupil",
                                        "ce:indexed-name": "Nastoupil LJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Transplant Cell Ther"
                        },
                        "ce:source-text": "Riedell PA, Hwang WT, Nastoupil LJ, et al. Patterns of use, outcomes, and resource utilization among recipients of commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B cell lymphomas. Transplant Cell Ther. 2022;28(10):669-676."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059-3068.",
                        "@reference-instance-id": "OB2BibRecID-950129089-f5f8061a578ea9e12211535da29223b9-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84903462466",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "32",
                                    "@issue": "27"
                                },
                                "pagerange": {
                                    "@first": "3059",
                                    "@last": "3068"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BD",
                                        "@_fa": "true",
                                        "ce:surname": "Cheson",
                                        "ce:indexed-name": "Cheson BD"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RI",
                                        "@_fa": "true",
                                        "ce:surname": "Fisher",
                                        "ce:indexed-name": "Fisher RI"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SF",
                                        "@_fa": "true",
                                        "ce:surname": "Barrington",
                                        "ce:indexed-name": "Barrington SF"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059-3068."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Lee DW, Santomasso BD, Locke FL, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019;25(4):625-638.",
                        "@reference-instance-id": "OB2BibRecID-950129089-249ad98a54b5bf569376bcd3f0cf3e43-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85062342961",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "25",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "625",
                                    "@last": "638"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DW",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee DW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BD",
                                        "@_fa": "true",
                                        "ce:surname": "Santomasso",
                                        "ce:indexed-name": "Santomasso BD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "FL",
                                        "@_fa": "true",
                                        "ce:surname": "Locke",
                                        "ce:indexed-name": "Locke FL"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Biol Blood Marrow Transplant"
                        },
                        "ce:source-text": "Lee DW, Santomasso BD, Locke FL, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019;25(4):625-638."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Diab A, Jenq RR, Rizzuto GA, et al. Enhanced responses to tumor immunization following total body irradiation are time-dependent. PLoS One. 2013; 8(12):e82496.",
                        "@reference-instance-id": "OB2BibRecID-950129089-1badc88376a85057f80429a06680b288-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Enhanced responses to tumor immunization following total body irradiation are time-dependent"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84892561171",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "12"
                                },
                                "pagerange": {"@first": "e82496"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Diab",
                                        "ce:indexed-name": "Diab A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RR",
                                        "@_fa": "true",
                                        "ce:surname": "Jenq",
                                        "ce:indexed-name": "Jenq RR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GA",
                                        "@_fa": "true",
                                        "ce:surname": "Rizzuto",
                                        "ce:indexed-name": "Rizzuto GA"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Diab A, Jenq RR, Rizzuto GA, et al. Enhanced responses to tumor immunization following total body irradiation are time-dependent. PLoS One. 2013; 8(12):e82496."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Alexander M, Culos K, Roddy J, et al. Chimeric antigen receptor T cell therapy: a comprehensive review of clinical efficacy, toxicity, and best practices for outpatient administration. Transplant Cell Ther. 2021;27(7):558-570.",
                        "@reference-instance-id": "OB2BibRecID-950129089-5bb914b0e97740f95a1c06ce92d057a4-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Chimeric antigen receptor T cell therapy: a comprehensive review of clinical efficacy, toxicity, and best practices for outpatient administration"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85107145357",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "558",
                                    "@last": "570"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Alexander",
                                        "ce:indexed-name": "Alexander M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Culos",
                                        "ce:indexed-name": "Culos K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Roddy",
                                        "ce:indexed-name": "Roddy J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Transplant Cell Ther"
                        },
                        "ce:source-text": "Alexander M, Culos K, Roddy J, et al. Chimeric antigen receptor T cell therapy: a comprehensive review of clinical efficacy, toxicity, and best practices for outpatient administration. Transplant Cell Ther. 2021;27(7):558-570."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Bansal R, Paludo J, Holland A, et al. Outpatient practice pattern and remote patient monitoring for axicabtagene ciloleucel CAR-T therapy in patients with aggressive lymphoma. J Clin Oncol. 2021;39(15_suppl):7554.",
                        "@reference-instance-id": "OB2BibRecID-950129089-4f95294a9cd632f343e82443834cf4cc-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Outpatient practice pattern and remote patient monitoring for axicabtagene ciloleucel CAR-T therapy in patients with aggressive lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85134030547",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "39"},
                                "pagerange": {"@first": "7554"}
                            },
                            "ref-text": "(15_suppl)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Bansal",
                                        "ce:indexed-name": "Bansal R"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Paludo",
                                        "ce:indexed-name": "Paludo J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Holland",
                                        "ce:indexed-name": "Holland A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Bansal R, Paludo J, Holland A, et al. Outpatient practice pattern and remote patient monitoring for axicabtagene ciloleucel CAR-T therapy in patients with aggressive lymphoma. J Clin Oncol. 2021;39(15_suppl):7554."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Nastoupil LJ, Jain MD, Feng L, et al. Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium. J Clin Oncol. 2020;38(27):3119-3128.",
                        "@reference-instance-id": "OB2BibRecID-950129089-46d98f6622bf889d5f421cbbba922674-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85086804860",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "38",
                                    "@issue": "27"
                                },
                                "pagerange": {
                                    "@first": "3119",
                                    "@last": "3128"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "LJ",
                                        "@_fa": "true",
                                        "ce:surname": "Nastoupil",
                                        "ce:indexed-name": "Nastoupil LJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MD",
                                        "@_fa": "true",
                                        "ce:surname": "Jain",
                                        "ce:indexed-name": "Jain MD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Feng",
                                        "ce:indexed-name": "Feng L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Nastoupil LJ, Jain MD, Feng L, et al. Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium. J Clin Oncol. 2020;38(27):3119-3128."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Chong EA, Ruella M, Schuster SJ; Lymphoma Program Investigators at the University of Pennsylvania. Five-year outcomes for refractory B-cell lymphomas with CAR T-cell therapy. N Engl J Med. 2021;384(7):673-674.",
                        "@reference-instance-id": "OB2BibRecID-950129089-98b35859fd7f51f119b0b3a9c315a127-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Five-year outcomes for refractory B-cell lymphomas with CAR T-cell therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85101296406",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "384",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "673",
                                    "@last": "674"
                                }
                            },
                            "ref-text": "Lymphoma Program Investigators at the University of Pennsylvania",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "EA",
                                    "@_fa": "true",
                                    "ce:surname": "Chong",
                                    "ce:indexed-name": "Chong EA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Ruella",
                                    "ce:indexed-name": "Ruella M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "SJ",
                                    "@_fa": "true",
                                    "ce:surname": "Schuster",
                                    "ce:indexed-name": "Schuster SJ"
                                }
                            ]},
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Chong EA, Ruella M, Schuster SJ; Lymphoma Program Investigators at the University of Pennsylvania. Five-year outcomes for refractory B-cell lymphomas with CAR T-cell therapy. N Engl J Med. 2021;384(7):673-674."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Bishop MR, Dickinson M, Purtill D, et al. Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma. N Engl J Med. 2022;386(7): 629-639.",
                        "@reference-instance-id": "OB2BibRecID-950129089-6f4e58ea7151cb5b0901a1e3d6ac80e5-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85122390017",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "386",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "629",
                                    "@last": "639"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MR",
                                        "@_fa": "true",
                                        "ce:surname": "Bishop",
                                        "ce:indexed-name": "Bishop MR"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Dickinson",
                                        "ce:indexed-name": "Dickinson M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Purtill",
                                        "ce:indexed-name": "Purtill D"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Bishop MR, Dickinson M, Purtill D, et al. Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma. N Engl J Med. 2022;386(7): 629-639."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Perales MA, Anderson LD Jr, Jain T, et al. Role of CD19 chimeric antigen receptor T cells in second-line large B cell lymphoma: lessons from phase 3 trials. An expert panel opinion from the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2022;28(9):546-559.",
                        "@reference-instance-id": "OB2BibRecID-950129089-eb0b61a10881eea1914bdf253a955e28-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Role of CD19 chimeric antigen receptor T cells in second-line large B cell lymphoma: lessons from phase 3 trials. An expert panel opinion from the American Society for Transplantation and Cellular Therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85135360795",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "546",
                                    "@last": "559"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MA",
                                        "@_fa": "true",
                                        "ce:surname": "Perales",
                                        "ce:indexed-name": "Perales MA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "LD",
                                        "@_fa": "true",
                                        "ce:surname": "Anderson",
                                        "ce:indexed-name": "Anderson LD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Jain",
                                        "ce:indexed-name": "Jain T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Transplant Cell Ther"
                        },
                        "ce:source-text": "Perales MA, Anderson LD Jr, Jain T, et al. Role of CD19 chimeric antigen receptor T cells in second-line large B cell lymphoma: lessons from phase 3 trials. An expert panel opinion from the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2022;28(9):546-559."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Sauter CS, Matasar MJ, Meikle J, et al. Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma. Blood. 2015;125(16):2579-2581.",
                        "@reference-instance-id": "OB2BibRecID-950129089-c8ecde4650dbb22f80a2d5e3f37445e9-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84927751342",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "125",
                                    "@issue": "16"
                                },
                                "pagerange": {
                                    "@first": "2579",
                                    "@last": "2581"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CS",
                                        "@_fa": "true",
                                        "ce:surname": "Sauter",
                                        "ce:indexed-name": "Sauter CS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MJ",
                                        "@_fa": "true",
                                        "ce:surname": "Matasar",
                                        "ce:indexed-name": "Matasar MJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Meikle",
                                        "ce:indexed-name": "Meikle J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Sauter CS, Matasar MJ, Meikle J, et al. Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma. Blood. 2015;125(16):2579-2581."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Armand P, Welch S, Kim HT, et al. Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era. Br J Haematol. 2013;160(5):608-617.",
                        "@reference-instance-id": "OB2BibRecID-950129089-e1e1d512bd4e453c16dda6b85958c200-21",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84873998239",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "160",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "608",
                                    "@last": "617"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Armand",
                                        "ce:indexed-name": "Armand P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Welch",
                                        "ce:indexed-name": "Welch S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "HT",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim HT"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Haematol"
                        },
                        "ce:source-text": "Armand P, Welch S, Kim HT, et al. Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era. Br J Haematol. 2013;160(5):608-617."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "New York",
            "@id": "60009343",
            "affilname": "Memorial Sloan-Kettering Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Madrid",
            "@id": "60033237",
            "affilname": "Hospital General Universitario Gregorio Marañón",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033237",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Minneapolis",
            "@id": "60029445",
            "affilname": "University of Minnesota Twin Cities",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029445",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chicago",
            "@id": "60029278",
            "affilname": "The University of Chicago",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029278",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Nashville",
            "@id": "60024890",
            "affilname": "Vanderbilt-Ingram Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024890",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Philadelphia",
            "@id": "60023009",
            "affilname": "Penn Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023009",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Portland",
            "@id": "60016733",
            "affilname": "Oregon Health &amp; Science University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016733",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Lawrence",
            "@id": "60015457",
            "affilname": "University of Kansas",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015457",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60015023",
            "affilname": "The University of Texas MD Anderson Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New York",
            "@id": "60007997",
            "affilname": "Weill Cornell Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85167904304",
        "dc:description": "CD19 chimeric antigen receptor (CAR) T-cell therapy represents a breakthrough for patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL), inducing sustained remissions in these patients. However, CAR T cells can result in significant toxicities. Preinfusion disease burden is associated with toxicities and outcomes after CAR T-cell therapy. We identified 33 patients with R/R DLBCL treated at 8 academic centers who had no detectable disease at the time of CAR T-cell therapy. The median time from leukapheresis to CAR T-cell infusion was 48 (19-193) days. Nine patients received axicabtagene ciloleucel, and 24 received tisagenlecleucel. There was no severe (grade ≥3) cytokine release syndrome, and only 1 patient developed severe neurotoxicity (grade 4). After a median follow-up of 16 months, 13 patients relapsed (39.4%) and 6 died (18.1%). One-year event-free survival and overall survival were 59.6% and 81.3%, respectively. Our findings suggest that, in patients with R/R DLBCL who have an indication for CAR T-cell therapy, treating patients in complete remission at the time of infusion is feasible, safe, and associated with favorable disease control. Further exploration in a larger clinical trial setting is warranted.",
        "pubmed-id": "36355838",
        "prism:coverDate": "2023-07-11",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85167904304",
        "dc:creator": {"author": [{
            "ce:given-name": "Kitsada",
            "preferred-name": {
                "ce:given-name": "Kitsada",
                "ce:initials": "K.",
                "ce:surname": "Wudhikarn",
                "ce:indexed-name": "Wudhikarn K."
            },
            "@seq": "1",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Wudhikarn",
            "@auid": "37091810400",
            "author-url": "https://api.elsevier.com/content/author/author_id/37091810400",
            "ce:indexed-name": "Wudhikarn K."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85167904304"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85167904304&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85167904304&origin=inward"
            }
        ],
        "source-id": "21100886825",
        "citedby-count": "5",
        "prism:volume": "7",
        "subtype": "ar",
        "dc:title": "Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy",
        "openaccess": "1",
        "prism:issn": "24739537 24739529",
        "publishercopyright": "© 2023 by The American Society of Hematology.",
        "prism:issueIdentifier": "13",
        "subtypeDescription": "Article",
        "prism:publicationName": "Blood Advances",
        "prism:pageRange": "3192-3198",
        "prism:endingPage": "3198",
        "openaccessFlag": "true",
        "prism:doi": "10.1182/bloodadvances.2022008294",
        "prism:startingPage": "3192",
        "dc:identifier": "SCOPUS_ID:85167904304",
        "dc:publisher": "American Society of Hematology"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Hematology",
        "@code": "2720",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Kitsada",
            "preferred-name": {
                "ce:given-name": "Kitsada",
                "ce:initials": "K.",
                "ce:surname": "Wudhikarn",
                "ce:indexed-name": "Wudhikarn K."
            },
            "@seq": "1",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Wudhikarn",
            "@auid": "37091810400",
            "author-url": "https://api.elsevier.com/content/author/author_id/37091810400",
            "ce:indexed-name": "Wudhikarn K."
        },
        {
            "ce:given-name": "Ana Alarcon",
            "preferred-name": {
                "ce:given-name": "Ana Alarcon",
                "ce:initials": "A.A.",
                "ce:surname": "Tomas",
                "ce:indexed-name": "Tomas A.A."
            },
            "@seq": "2",
            "ce:initials": "A.A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60033237",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033237"
                }
            ],
            "ce:surname": "Tomas",
            "@auid": "57216155516",
            "author-url": "https://api.elsevier.com/content/author/author_id/57216155516",
            "ce:indexed-name": "Tomas A.A."
        },
        {
            "ce:given-name": "Jessica R.",
            "preferred-name": {
                "ce:given-name": "Jessica R.",
                "ce:initials": "J.R.",
                "ce:surname": "Flynn",
                "ce:indexed-name": "Flynn J.R."
            },
            "@seq": "3",
            "ce:initials": "J.R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009343",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
            },
            "ce:surname": "Flynn",
            "@auid": "57203165820",
            "author-url": "https://api.elsevier.com/content/author/author_id/57203165820",
            "ce:indexed-name": "Flynn J.R."
        },
        {
            "ce:given-name": "Sean M.",
            "preferred-name": {
                "ce:given-name": "Sean M.",
                "ce:initials": "S.M.",
                "ce:surname": "Devlin",
                "ce:indexed-name": "Devlin S.M."
            },
            "@seq": "4",
            "ce:initials": "S.M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009343",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
            },
            "ce:surname": "Devlin",
            "@auid": "55515156100",
            "author-url": "https://api.elsevier.com/content/author/author_id/55515156100",
            "ce:indexed-name": "Devlin S.M."
        },
        {
            "ce:given-name": "Jamie",
            "preferred-name": {
                "ce:given-name": "Jamie",
                "ce:initials": "J.",
                "ce:surname": "Brower",
                "ce:indexed-name": "Brower J."
            },
            "@seq": "5",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60023009",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023009"
            },
            "ce:surname": "Brower",
            "@auid": "57057255300",
            "author-url": "https://api.elsevier.com/content/author/author_id/57057255300",
            "ce:indexed-name": "Brower J."
        },
        {
            "ce:given-name": "Veronika",
            "preferred-name": {
                "ce:given-name": "Veronika",
                "ce:initials": "V.",
                "ce:surname": "Bachanova",
                "ce:indexed-name": "Bachanova V."
            },
            "@seq": "6",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60029445",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029445"
            },
            "ce:surname": "Bachanova",
            "@auid": "23975811700",
            "author-url": "https://api.elsevier.com/content/author/author_id/23975811700",
            "ce:indexed-name": "Bachanova V."
        },
        {
            "ce:given-name": "Loretta J.",
            "preferred-name": {
                "ce:given-name": "Loretta J.",
                "ce:initials": "L.J.",
                "ce:surname": "Nastoupil",
                "ce:indexed-name": "Nastoupil L.J."
            },
            "@seq": "7",
            "ce:initials": "L.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015023",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015023"
            },
            "ce:surname": "Nastoupil",
            "@auid": "55208211700",
            "author-url": "https://api.elsevier.com/content/author/author_id/55208211700",
            "ce:indexed-name": "Nastoupil L.J."
        },
        {
            "ce:given-name": "Joseph P.",
            "preferred-name": {
                "ce:given-name": "Joseph P.",
                "ce:initials": "J.P.",
                "ce:surname": "McGuirk",
                "ce:indexed-name": "McGuirk J.P."
            },
            "@seq": "8",
            "ce:initials": "J.P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015457",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015457"
            },
            "ce:surname": "McGuirk",
            "@auid": "7005232105",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005232105",
            "ce:indexed-name": "McGuirk J.P."
        },
        {
            "ce:given-name": "Richard T.",
            "preferred-name": {
                "ce:given-name": "Richard T.",
                "ce:initials": "R.T.",
                "ce:surname": "Maziarz",
                "ce:indexed-name": "Maziarz R.T."
            },
            "@seq": "9",
            "ce:initials": "R.T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016733",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016733"
            },
            "ce:surname": "Maziarz",
            "@auid": "7004295697",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004295697",
            "ce:indexed-name": "Maziarz R.T."
        },
        {
            "ce:given-name": "Olalekan O.",
            "preferred-name": {
                "ce:given-name": "Olalekan O.",
                "ce:initials": "O.O.",
                "ce:surname": "Oluwole",
                "ce:indexed-name": "Oluwole O.O."
            },
            "@seq": "10",
            "ce:initials": "O.O.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60024890",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024890"
            },
            "ce:surname": "Oluwole",
            "@auid": "55744271900",
            "author-url": "https://api.elsevier.com/content/author/author_id/55744271900",
            "ce:indexed-name": "Oluwole O.O."
        },
        {
            "ce:given-name": "Stephen J.",
            "preferred-name": {
                "ce:given-name": "Stephen J.",
                "ce:initials": "S.J.",
                "ce:surname": "Schuster",
                "ce:indexed-name": "Schuster S.J."
            },
            "@seq": "11",
            "ce:initials": "S.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60023009",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023009"
            },
            "ce:surname": "Schuster",
            "@auid": "7202029256",
            "author-url": "https://api.elsevier.com/content/author/author_id/7202029256",
            "ce:indexed-name": "Schuster S.J."
        },
        {
            "ce:given-name": "David L.",
            "preferred-name": {
                "ce:given-name": "David L.",
                "ce:initials": "D.L.",
                "ce:surname": "Porter",
                "ce:indexed-name": "Porter D.L."
            },
            "@seq": "12",
            "ce:initials": "D.L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60023009",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023009"
            },
            "ce:surname": "Porter",
            "@auid": "13605387900",
            "author-url": "https://api.elsevier.com/content/author/author_id/13605387900",
            "ce:indexed-name": "Porter D.L."
        },
        {
            "ce:given-name": "Michael R.",
            "preferred-name": {
                "ce:given-name": "Michael R.",
                "ce:initials": "M.R.",
                "ce:surname": "Bishop",
                "ce:indexed-name": "Bishop M.R."
            },
            "@seq": "13",
            "ce:initials": "M.R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60029278",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029278"
            },
            "ce:surname": "Bishop",
            "@auid": "35413554300",
            "author-url": "https://api.elsevier.com/content/author/author_id/35413554300",
            "ce:indexed-name": "Bishop M.R."
        },
        {
            "ce:given-name": "Peter A.",
            "preferred-name": {
                "ce:given-name": "Peter A.",
                "ce:initials": "P.A.",
                "ce:surname": "Riedell",
                "ce:indexed-name": "Riedell P.A."
            },
            "@seq": "14",
            "ce:initials": "P.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60029278",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029278"
            },
            "ce:surname": "Riedell",
            "@auid": "56210729200",
            "author-url": "https://api.elsevier.com/content/author/author_id/56210729200",
            "ce:indexed-name": "Riedell P.A."
        },
        {
            "ce:given-name": "Miguel-Angel",
            "preferred-name": {
                "ce:given-name": "Miguel Angel",
                "ce:initials": "M.A.",
                "ce:surname": "Perales",
                "ce:indexed-name": "Perales M.A."
            },
            "@seq": "15",
            "ce:initials": "M.-A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60009343",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009343"
                },
                {
                    "@id": "60007997",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007997"
                }
            ],
            "ce:surname": "Perales",
            "@auid": "6701893624",
            "author-url": "https://api.elsevier.com/content/author/author_id/6701893624",
            "ce:indexed-name": "Perales M.-A."
        }
    ]}
}}